進行期の乳房外パジェット癌に対する抗アンドロゲン療法の試み Total Androgen Blockade Therapy for an Advanced of Extramammary Paget's carcinoma

この論文にアクセスする

この論文をさがす

著者

抄録

Growth dependence with androgen (Nishi J Natl Cancer Inst 84: 519, 1992) and frequent expression of structurally unaltered androgen receptor (Fujimoto Lab Invest 80: 1465, 2000) in Extramammary Paget's disease (EMPD) may provide arational basis for hormone therapy. We report the first attempt of total androgen blockade (TAB) therapy in a 78-year-old man with advanced EMPD. The TAB therapy, which is widely used for prostate cancer, consisted. of oral administration of chlormadinone acetate 100mg daily and subcutaneous injection of leuprorelin acetate 3.75mg every month. Although skin metastases on his lower abdomen gradually progressed, para-trachial lymphadenopathy disappeared and para-aortic lymph nodes decreased in size by more than 60%. He died of the disease one year after starting the TAB therapy. Future clinical trial is required to establish the role of TAB therapy in the management of advanced stage EMPD patients. [<i>Skin Cancer (Japan)</i> 2001; 16: 247-250]

収録刊行物

  • Skin cancer : official organ of the Japanese Society for Skin Cancer = 皮膚悪性腫瘍研究会機関誌

    Skin cancer : official organ of the Japanese Society for Skin Cancer = 皮膚悪性腫瘍研究会機関誌 16(2), 247-250, 2001-10-31

    日本皮膚悪性腫瘍学会

参考文献:  10件中 1-10件 を表示

被引用文献:  9件中 1-9件 を表示

各種コード

  • NII論文ID(NAID)
    10013030669
  • NII書誌ID(NCID)
    AN10087647
  • 本文言語コード
    JPN
  • 資料種別
    NOT
  • ISSN
    09153535
  • データ提供元
    CJP書誌  CJP引用  J-STAGE 
ページトップへ